Health & Medicine

Gene Biotherapeutics Secures Investment from Nostrum Pharmaceuticals, LLC

        SAN DIEGO, CA – June 01, 2020 – Gene Biotherapeutics Inc. (OTC:CRXM, formerly Taxus...

Arog Pharmaceuticals to Present Data at the 2020 European Hematology Association Virtual Congress

Dallas, May 15, 2020 - - Arog Pharmaceuticals, Inc., a Phase 3 biopharmaceutical company focused on the development of crenolanib...

Paras Biopharmaceuticals Successfully Develops Cytofold StructQuant® Technology for Cytoplasmic Disulphide Formation, (for Active Folding) for Complex Therapeutic Proteins

Paras Biopharmaceuticals Finland Oy is pleased to announce that its proprietary technology, Cytofold StructQuant®,...

International delegation of women to gather at Wayne Pharmaceuticals for Empowerment Conference

Wayne Pharmaceuticals will serve as the Headline Sponsor for the 5th Annual International indigoLife Women’s Empowerment...

Reuters to make documentary on Paras Biopharmaceuticals Finland Oy – Innovations in Biologics: Insights of a leading expert.

Paras Biopharmaceuticals Finland Oy is proud to announce that Reuters.com / Reuters Plus has selected our Finland-based company,...

Jayendrakumar Patel selected as Top Pharmaceutical Scientist of the Year by the International Association of Top Professionals (IAOTP)

Mr. Jayendrakumar Patel, CEO at Pyrrhic Pharma Pvt Ltd, and Deputy Manager at Cadila Healthcare LTD., was just recently selected...

Is Aytu BioScience (NasdaqCM: AYTU) Building Another Arbor Pharmaceuticals?...Investors Say Yes

Is Aytu BioScience (NasdaqCM: AYTU) finally getting the investor attention it deserves? Well, if the increase in the share...

Immune Pharmaceuticals Announces Leadership Transition

Immune Pharmaceuticals, Inc.(OTC PINK: IMNPQ) (“Immune” or the “Company”), a biopharmaceutical company...

Paras Biopharmaceuticals Finland Oy Announces Successful Development of Biologically Active Romiplostim (N-Plate® Biosimilar) Production Technology

PARAS BIOPHARMACEUTICALS FINLAND OY today announced the achievement of a major milestone – the successful development...

Andarix Pharmaceuticals to Present Lung Cancer Clinical Trial Results at the Society of Nuclear Medicine Meeting.

SOMERVILLE, MA — October 26, 2018— Andarix Pharmaceuticals, a leader in the discovery and development of targeted...

CellPoint, L.L.C. announced today that it has entered into automated production agreementwith KP Pharmaceutical Technology for lead molecular imaging agent Oncardia®

CellPoint announced today that it has entered into an automated production agreement with KP Pharmaceutical Technology, Inc....

Dr. Richard Guarino selected as Top Pharmaceutical Executive of the Year by the International Association of Top Professionals (IAOTP)

Richard A. Guarino, MD, KM, President of Oxford Pharmaceutical Resources Inc., Vice President of Medical Affairs for Validus...